ClinConnect ClinConnect Logo
Search / Trial NCT06897618

Culturally Tailored Diabetes Education on Self-Management of Adult Hispanic Males With Type 2 Diabetes Mellitus

Launched by HACKENSACK MERIDIAN HEALTH · Mar 20, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Type 2 Diabetes Self Management Behaviors Culturally Tailored Diabetes Education

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Age: Adult Hispanic males 18-64 at time of study intervention.
  • Diagnosis Codes: Patients with self-reported diagnosis of T2DM without complex, co-morbid conditions such as severe kidney disease and terminal illnesses such as cancer.
  • English or Spanish speaking
  • Exclusion Criteria:
  • Outside the age range listed above
  • Without a diagnosis of type 2 diabetes

Trial Officials

Beryl O'Donnell, MSN, RN, NP-C

Principal Investigator

Hackensack Meridian Health

About Hackensack Meridian Health

Hackensack Meridian Health is a leading healthcare organization based in New Jersey, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical research, Hackensack Meridian Health is committed to fostering collaboration between researchers, healthcare professionals, and patients to develop and evaluate cutting-edge therapies and interventions. With a focus on enhancing health outcomes and addressing pressing medical needs, the organization leverages its extensive network of hospitals, specialty care centers, and research facilities to advance clinical knowledge and contribute to the global body of medical science.

Locations

Plainfield, New Jersey, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported